Free CME from PeerView


Geriatrics CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option
Andrew Blauvelt, MD, MBA
June 21, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Leading the Way in Multiple Myeloma: Nurse Perspectives on Recent Developments With Novel Therapeutics
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN
June 21, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
April W. Armstrong, MD, MPH
June 17, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference
Steven W. Pipe, MD
June 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
Jinsy A. Andrews, MD, MSc, FAAN
June 08, 2021
Credits: 0.75 CME / MOC / NCPD
Medical Learning Institute, Inc.
Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast Cancer: Can New HER2-Targeted Therapies Address Unmet Needs and Offer Better Options for Challenging Patient Populations?
Shanu Modi, MD
June 01, 2021
Credits: 1.50 CME / MOC
University of Florida College of Medicine
Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD
Professor Kausik Ray
May 27, 2021
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Advancing Care for People Living With Moderate to Severe Atopic Dermatitis: The Future Looks Clear
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
May 26, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy
Cedric "Jamie" Rutland, MD
May 25, 2021
Credits: 1.00 CME / CC
Medical Learning Institute, Inc.
Immune Checkpoint Inhibitor Therapy for Locally Advanced and Early-Stage Esophageal/GEJ Cancer: The Latest Evidence and Implications for Thoracic Surgeons and the Multidisciplinary Care Team
Ronan J. Kelly, MD, MBA
May 25, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer
Brendon M. Stiles, MD
May 21, 2021
Elizabeth A. Raetz, MD / Rachel Rau, MD
Medical Learning Institute, Inc.
Meeting Therapeutic Challenges in Pediatric ALL: Expert Perspectives on the Use of Asparaginase Compounds
Elizabeth A. Raetz, MD / Rachel Rau, MD
May 19, 2021
Medical Learning Institute, Inc.
Changing Times in DLBCL: Oncology Nurse Insight on the Practicalities of Antibody Therapy
Lesley Camille Ballance, MSN, FNP-BC
May 17, 2021
Medical Learning Institute, Inc.
The New Therapeutic Era in Renal Cell Carcinoma: Essentials for Team-Based Patient Care
May 17, 2021
Medical Learning Institute, Inc.
Making Modern Treatment Choices in CLL: Oncology Nurse Insights on the Patient Journey and the New Era of Care
Amy Goodrich, CRNP
May 12, 2021
Medical Learning Institute, Inc.
Making Sense of the New World of Myeloma Care: Pharmacy Perspectives on Novel Antibodies and BCMA CAR-T Therapy
R. Donald Harvey, BCOP, FCCP, FHOPA
May 12, 2021
Medical Learning Institute, Inc.
Enhancing Personalized Medicine in Advanced Ovarian Cancer: Expert Guidance on Integrating the Latest Updates on PARP Inhibitors and Novel Therapeutic Innovations Into Your Clinical Practice
May 11, 2021
Medical Learning Institute, Inc.
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
Suresh S. Ramalingam, MD, FACP, FASCO
May 11, 2021
Medical Learning Institute, Inc.
The Importance of Early Recognition of Interstitial Lung Diseases: Practical Strategies for the Radiologist
Brett Elicker, MD
May 10, 2021
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
May 07, 2021
Medical Learning Institute, Inc.
Therapeutic Advancements in Myelodysplastic Syndromes: Bridging the Gap Between Patient Safety and Quality Care Through the Latest Science and Evidence-Based Learning in Nursing Practice
Sara M. Tinsley, PhD, APRN, AOCN
May 07, 2021
Medical Learning Institute, Inc.
Visualizing Progress for TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles and Modern Treatment
Joseph D. Khoury, MD, FCAP
May 05, 2021
Medical Learning Institute, Inc.
The Rise of B-Cell Therapies in Relapsing MS: Examining the State of the Science, New Therapeutic Options, and Patient-Centered Clinical Decision-Making
Ludwig Kappos, MD, FEAN, FAAN
May 04, 2021
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS
May 03, 2021
Medical Learning Institute, Inc.
Simulation – Striking a Balance: Weighing the Benefits and Risks of Treatment With Direct Oral Anticoagulants in Individuals With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Sean Pokorney, MD, MBA
April 21, 2021
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Matthew D. Galsky, MD
April 20, 2021
Medical Learning Institute, Inc.
Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
Naval Daver, MD
April 14, 2021
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
Medical Learning Institute, Inc.
At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
April 14, 2021
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
April 13, 2021
Medical Learning Institute, Inc.
Optimizing Patient Outcomes in RCC Through Safe and Efficacious Use of Immuno-Oncology and Targeted Approaches: Teaming Up to Mitigate and Manage Adverse Events and Maximize Survival
Brian I. Rini, MD, FASCO
April 12, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView